Cargando…
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
BACKGROUND: Huntington's disease (HD) is a neurodegenerative disorder caused by the expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic pathways underlying HD involve the impairment of cellular energy homeostasis and DNA damage in the brain. The protein kina...
Autores principales: | Hua, Kuo-Feng, Chao, A-Ching, Lin, Ting-Yu, Chen, Wan-Tze, Lee, Yu-Chieh, Hsu, Wan-Han, Lee, Sheau-Long, Wang, Hsin-Min, Yang, Ding-I., Ju, Tz-Chuen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270658/ https://www.ncbi.nlm.nih.gov/pubmed/35818427 http://dx.doi.org/10.1016/j.jgr.2021.11.003 |
Ejemplares similares
-
Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease
por: Ju, Tz-Chuen, et al.
Publicado: (2011) -
Etoposide Induces ATM-Dependent Mitochondrial Biogenesis through AMPK Activation
por: Fu, Xuan, et al.
Publicado: (2008) -
Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis
por: Liu, Bingli, et al.
Publicado: (2023) -
Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice
por: Lin, Tsai-Jung, et al.
Publicado: (2019) -
AMPK amplifies Huntington's disease
por: Short, Ben
Publicado: (2011)